Cargando…
Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Autores principales: | Li, Ting, Gu, Liyang, Wang, Xiaodong, Guo, Li, Shi, Hui, Yang, Chengde, Chen, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281664/ https://www.ncbi.nlm.nih.gov/pubmed/30518948 http://dx.doi.org/10.1038/s41598-018-36662-z |
Ejemplares similares
-
A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2017) -
Publisher Correction: Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still’s disease
por: Han, Jae Ho, et al.
Publicado: (2022) -
Publisher Correction: A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy
por: Lopez, Gabriel, et al.
Publicado: (2023) -
Publisher Correction: Publisher correction for multiple articles
Publicado: (2022) -
Publisher Correction to: Time of onset and/or diagnosis of ADHD in European children: a systematic review
por: Rocco, Ilaria, et al.
Publicado: (2022)